世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

前臨床CRO市場規模、シェア、動向:サービス別(バイオアナリシス・DMPK研究、毒性検査)、エンドユーズ別(バイオ医薬品企業、医療機器企業)分析とセグメント予測 2020-2027年

Preclinical CRO Market Size, Share & Trends Analysis Report By Services (Bioanalysis & DMPK Studies, Toxicology Testing), By End Use (Biopharmaceutical Companies, Medical Device Companies), And Segment Forecasts, 2020 - 2027

 

出版社 出版年月電子版価格 ページ数
Grand View Research
グランドビューリサーチ
2020年3月US$5,950
シングルユーザライセンス
94

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは前臨床CRO市場を分析・予測したGrand View Researchの市場調査報告書です。

Overview

The global preclinical CRO market size is expected to reach USD 7.8 billion by 2027, registering a CAGR of 8.3% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trend, which is expected to increase the demand for preclinical trials in the future. Whereas rise in number of complex drugs entering clinical trials and increasing R&D expenses are some of the factors responsible for the preclinical Contract Research Organization (CRO) growth. Increasing prices and changes in reimbursement policies are also anticipated to boost the in emerging countries such as India and China.

Increasing number of new entrants in market is anticipated to help the market to grow during the forecast period. Various companies are focusing on research and development of new drugs and therefore are outsourcing these activities to launch efficient CRO services in the market.

Further key findings from the report suggest:

- Toxicology testing held the largest share in the service segment in 2019 due to increasing trend of outsourcing, especially in emerging countries

- Bioanalysis is expected to grow with the highest CAGR of 8.8% over the forecast period

- North America dominates the market with the largest share of 47.5% in 2019 owing to advanced healthcare infrastructure in the region

- The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to government support in development of outsourcing hubs along with availability of skilled practitioners

- Some of the key preclinical CRO market players are Envigo Corporation, MPI research, and Eurofins Scientific.



目次

Table of Contents

Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and end-use scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Preclinical CRO Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Suring number of drugs in preclinical phases
3.4.1.2. Economies of production and scale
3.4.1.3. Increasing R&D expenditure
3.4.2. Market Restraint Analysis
3.4.2.1. High labor cost
3.4.2.2. Stringent regulatory policies
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Preclinical CRO: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
Chapter 4. Preclinical CRO Market : Segment Analysis, by Services, 2016 - 2027 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global Preclinical CRO Market, by services, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
4.5.1. Bioanalysis and DMPK studies
4.5.2. Toxicology testing
4.5.3. Others
Chapter 5. Preclinical CRO Market : Segment Analysis, By End-use, 2016 - 2027 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global Preclinical CRO market, by end-use, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Biopharmaceutical companies
5.5.2. Government and academic institutes
5.5.3. Medical device companies
Chapter 6. Preclinical CRO Market : Regional Market Analysis, By Services, 2016 - 2027 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2019 & 2027
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.7.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.8.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.9. Netherlands
6.8.9.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.9.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.10. Belgium
6.8.10.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.10.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.11. Switzerland
6.8.11.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.11.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.12. Russia
6.8.12.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.12.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.8.13. Sweden
6.8.13.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.13.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.9.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.9. Malaysia
6.9.9.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.9.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.10. Indonesia
6.9.11. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.12. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.13. Singapore
6.9.14. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.15. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.16. Philippines
6.9.17. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.18. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.9.19. Thailand
6.9.20. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.21. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.10.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.4. Brazil
6.10.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.5. Mexico
6.10.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.6. Argentina
6.10.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.7. Colombia
6.10.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.10.8. Chile
6.10.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11. Middle East and Africa
6.11.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.11.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.3. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.4. South Africa
6.11.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.4.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.5. Saudi Arabia
6.11.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.5.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.6. UAE
6.11.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.6.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.7. Israel
6.11.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.7.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
6.11.8. Egypt
6.11.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.8.2. Market estimates and forecast, by End-use, 2016 - 2027 (USD Million)
Chapter 7. Preclinical CRO Market - Competitive Analysis
7.1. Key companies profiled
7.1.1. Envigo Corporation
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. MPI research
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Eurofins Scientific
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. PRA Health Sciences, Inc
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Wuxi AppTec
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Medpace, Inc.
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Pharmaceutical Product Development (PPD), LLC
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. PARAXEL International Corporation
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. ICON Plc.
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Laboratory Corporation of America, Inc.
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives

List of Tables

これ以降の目次はメールでお送りいたします。データリソースまでお申し付けください。

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る